Trials / Completed
CompletedNCT01971632
A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 463 (actual)
- Sponsor
- Mundipharma Research GmbH & Co KG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective was to demonstrate the superiority of OXN over placebo over time from the initial dose of study medication to multiple pain events (inadequate analgesia) during the double blind phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone & naloxone combination, prolonged release | |
| DRUG | placebo oxycodone / naloxone |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2013-10-29
- Last updated
- 2018-10-23
Source: ClinicalTrials.gov record NCT01971632. Inclusion in this directory is not an endorsement.